Both in Pharmaceuticals
Gossamer Bio vs RenovoRx
Over the past year GOSS returned −94.9% and RNXT returned +33.1%; their daily moves had a correlation of -0.06.
GOSS −94.9% RNXT +33.1%Growth of $1, one year, split-adjusted
| Metric | GOSS | RNXT |
|---|---|---|
| Price | $11.58 | $1.57 |
| Market cap | $70.8M | $70.9M |
| Today | +0.52% | +1.29% |
| 1 month | −14.9% | −6.0% |
| 6 months | −54.8% | +46.7% |
| Year to date | −95.3% | +86.9% |
| 1 year | −94.6% | +33.1% |
| Revenue growth (YoY) | −19.6% | +115.4% |
| Gross margin | 100.0% | 84.3% |
| Net margin | 182.9% | −320.2% |
| P/E (TTM) | — | — |
| Price / sales | 1.3× | 35.9× |
| Net cash | $20.9M | $9.5M |
| Dividend yield | — | — |
| Volatility (60d) | 1,269.6% | 107.0% |
| Short % of float | 16.4% | 1.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).